Using hydrogen peroxide to prevent antibody disulfide bond reduction during manufacturing process. Issue 3 (3rd April 2018)
- Record Type:
- Journal Article
- Title:
- Using hydrogen peroxide to prevent antibody disulfide bond reduction during manufacturing process. Issue 3 (3rd April 2018)
- Main Title:
- Using hydrogen peroxide to prevent antibody disulfide bond reduction during manufacturing process
- Authors:
- Du, Cheng
Huang, Yunping
Borwankar, Ameya
Tan, Zhijun
Cura, Anthony
Yee, Joon Chong
Singh, Nripen
Ludwig, Richard
Borys, Michael
Ghose, Sanchayita
Mussa, Nesredin
Li, Zheng Jian - Abstract:
- ABSTRACT: During large-scale monoclonal antibody manufacturing, disulfide bond reduction of antibodies, which results in generation of low molecule weight species, is occasionally observed. When this happens, the drug substance does not meet specifications. Many investigations have been conducted across the biopharmaceutical industry to identify the root causes, and multiple strategies have been proposed to mitigate the problem. The reduction is correlated with the release of cellular reducing components and depletion of dissolved oxygen before, during, and after harvest. Consequently, these factors can lead to disulfide reduction over long-duration storage at room temperature prior to Protein A chromatography. Several strategies have been developed to minimize antibody reduction, including chemical inhibition of reducing components, maintaining aeration before and after harvest, and chilling clarified harvest during holding. Here, we explore the use of hydrogen peroxide in clarified harvest bulk or cell culture fluid as a strategy to prevent disulfide reduction. A lab-scale study was performed to demonstrate the effectiveness of hydrogen peroxide in preventing antibody reduction using multiple IgG molecules. Studies were done to define the optimal concentration of hydrogen peroxide needed to avoid unnecessary oxidization of the antibody products. We show that adding a controlled amount of hydrogen peroxide does not change product quality attributes of the protein. SinceABSTRACT: During large-scale monoclonal antibody manufacturing, disulfide bond reduction of antibodies, which results in generation of low molecule weight species, is occasionally observed. When this happens, the drug substance does not meet specifications. Many investigations have been conducted across the biopharmaceutical industry to identify the root causes, and multiple strategies have been proposed to mitigate the problem. The reduction is correlated with the release of cellular reducing components and depletion of dissolved oxygen before, during, and after harvest. Consequently, these factors can lead to disulfide reduction over long-duration storage at room temperature prior to Protein A chromatography. Several strategies have been developed to minimize antibody reduction, including chemical inhibition of reducing components, maintaining aeration before and after harvest, and chilling clarified harvest during holding. Here, we explore the use of hydrogen peroxide in clarified harvest bulk or cell culture fluid as a strategy to prevent disulfide reduction. A lab-scale study was performed to demonstrate the effectiveness of hydrogen peroxide in preventing antibody reduction using multiple IgG molecules. Studies were done to define the optimal concentration of hydrogen peroxide needed to avoid unnecessary oxidization of the antibody products. We show that adding a controlled amount of hydrogen peroxide does not change product quality attributes of the protein. Since hydrogen peroxide is soluble in aqueous solutions and decomposes into water and oxygen, there is no additional burden involved in removing it during the downstream purification steps. Due to its ease of use and minimal product impact, we demonstrate that hydrogen peroxide treatment is a powerful, simple tool to quench reducing potential by simply mixing it with harvested cell culture fluid. … (more)
- Is Part Of:
- MAbs. Volume 10:Issue 3(2018)
- Journal:
- MAbs
- Issue:
- Volume 10:Issue 3(2018)
- Issue Display:
- Volume 10, Issue 3 (2018)
- Year:
- 2018
- Volume:
- 10
- Issue:
- 3
- Issue Sort Value:
- 2018-0010-0003-0000
- Page Start:
- 500
- Page End:
- 510
- Publication Date:
- 2018-04-03
- Subjects:
- antibody -- disulfide bonds -- reduction -- hydrogen peroxide -- mAb manufacturing
Monoclonal antibodies -- Therapeutic use -- Periodicals
Monoclonal antibodies -- Periodicals
Antibodies, Monoclonal -- Periodicals
616.0798 - Journal URLs:
- http://www.tandfonline.com/loi/kmab20#.VufTUVLcuic ↗
http://www.landesbioscience.com/journals/mabs ↗
http://www.tandfonline.com/ ↗ - DOI:
- 10.1080/19420862.2018.1424609 ↗
- Languages:
- English
- ISSNs:
- 1942-0862
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5320.243000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 6564.xml